Vyant Bio, Inc. Quarterly Common Stock, Shares, Issued from Q4 2012 to Q4 2022

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Vyant Bio, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2012 to Q4 2022.
  • Vyant Bio, Inc. Common Stock, Shares, Issued for the quarter ending December 31, 2022 was 5.92M shares, a 2.14% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 5.92M +124K +2.14% Dec 31, 2022 10-K 2023-03-31
Q3 2022 5.88M -23.1M -79.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 29.4M Jun 30, 2022 10-Q 2022-08-22
Q1 2022 29.4M +427K +1.47% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 5.8M +3.2M +124% Dec 31, 2021 10-K 2023-03-31
Q3 2021 29M +26.5M +1057% Sep 30, 2021 10-Q 2021-11-12
Q1 2021 29M +26.9M +1276% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 2.59M +490K +23.3% Dec 31, 2020 10-K 2022-03-30
Q3 2020 2.51M +405K +19.3% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 2.26M -55.6M -96.1% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 2.11M -54.2M -96.3% Mar 31, 2020 10-Q 2020-06-24
Q4 2019 2.1M +1.18M +128% Dec 31, 2019 10-K 2021-03-31
Q3 2019 2.1M -25.6M -92.4% Sep 30, 2019 10-Q 2019-11-19
Q2 2019 57.8M +30.1M +109% Jun 30, 2019 10-Q 2019-08-19
Q1 2019 56.3M +28.5M +103% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 924K -26.8M -96.7% Dec 31, 2018 10-K 2020-05-29
Q3 2018 27.7M +3.47M +14.3% Sep 30, 2018 10-Q 2018-11-19
Q2 2018 27.7M +7.94M +40.1% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 27.7M +7.97M +40.4% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 27.8M +8.82M +46.6% Dec 31, 2017 10-K 2019-04-16
Q3 2017 24.3M +5.38M +28.5% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 19.8M +3.67M +22.7% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 19.8M +6.1M +44.7% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 18.9M +5.28M +38.7% Dec 31, 2016 10-K 2018-04-02
Q3 2016 18.9M +9.01M +91.4% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 16.1M +6.28M +63.7% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 13.7M +3.82M +38.9% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 13.7M +3.83M +39% Dec 31, 2015 10-K 2017-03-23
Q3 2015 9.86M +138K +1.42% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 9.84M +380K +4.01% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 9.83M +549K +5.91% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 9.82M +546K +5.88% Dec 31, 2014 10-K 2016-03-10
Q3 2014 9.72M +3.76M +63% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 9.46M +5.15M +119% Jun 30, 2014 10-Q/A 2014-09-23
Q1 2014 9.28M +7.93M +588% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 9.28M +7.93M +587% Dec 31, 2013 10-K 2015-03-16
Q3 2013 5.97M Sep 30, 2013 10-Q 2013-11-13
Q2 2013 4.32M Jun 30, 2013 10-Q 2013-08-05
Q1 2013 1.35M Mar 31, 2013 10-Q/A 2013-06-04
Q4 2012 1.35M Dec 31, 2012 10-K 2014-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.